Skip to content

Transcranial Temporal Interference Stimulation In Severely Brain Injured Patients With Disorders of Consciousness

An Exploratory Trial Evaluating Temporal Interference Stimulation of CM-pf In Patients With Disorders of Consciousness

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06851156
Enrollment
10
Registered
2025-02-28
Start date
2025-04-07
Completion date
2025-12-31
Last updated
2025-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disorders of Consciousness, Minimally Conscious State, Severe Brain Injury, Unresponsive Wakefulness Syndrome

Brief summary

The purpose of this academic lead study is to explore the effect of noninvasive neuromodulation of the CM-pf via tTIS for patients with disorders of consciousness.

Interventions

DEVICEtTIS

CM-pf tTIS

Sponsors

Xijing Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* traumatic and nontraumatic etiology of VS/UWS or MCS according to published diagnostic criteria.

Exclusion criteria

* patients in coma, with less than 1 week after acute brain insult, with fluctuating diagnosis on baseline assessment, and with a metallic cerebral implant or pacemaker, and with epilepsy.

Design outcomes

Primary

MeasureTime frameDescription
CRS-R total score changesFrom enrollment to the end of treatment at 10 daysComa Recovery Scale-Revised scale score, with score ranging from 0 to 23, was used to evaluate the consciousness condition.

Secondary

MeasureTime frameDescription
Numbers of patients with improved consciousnessFrom enrollment to the end of treatment at 10 days
EEG changesFrom enrollment to the end of treatment at 10 daysEEG power spectra, Connectivity and ABCD model, etc

Countries

China

Contacts

Primary ContactGengyao Hu
304517021@qq.com86-15399059833

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026